Your browser doesn't support javascript.
Feasibility Study of Adhera® Fatigue Digital Program for Patients With Long COVID-related Fatigue
ClinicalTrials.gov; 18/11/2022; TrialID: NCT05631171
Clinical Trial Register | ICTRP | ID: ictrp-NCT05631171
ABSTRACT

Condition

Post-Acute COVID19 Syndrome;Fatigue

Intervention

Behavioral Adhera® Fatigue Digital Program

Primary 

outcome:

Health-related quality of life;Health-related quality of life;Health-related quality of life;Fatigue;Fatigue;Fatigue;Emotional wellness;Emotional wellness;Emotional wellness

Criteria


Inclusion Criteria

- Individuals over 18 years of age.

- With long COVID, according to the World Health Organization (WHO) consensus definition

- Having a history of fatigue symptoms

- Obtain a score between 4 and 10 on the question "By how much do you rate your fatigue
level from 0 to 10 in the last 7 days?", where 0 is no fatigue and 10 is the worst
fatigue imaginable

- Have an Android or iOS smartphone compatible with the intervention program.

- Agree to participate in the study and sign the informed consent form

- Willingness and availability to comply with all study guidelines and procedures

Exclusion Criteria

- Hospital admission during the period of study participation.

- Participation in another study with pharmacological treatment

- Patients who are not technologically literate or unable to use the mobile application.

- Known severe psychiatric illness or presence of relevant cognitive impairment, at the
discretion of the recruiting physician

- With mobility restrictions that limit the patient's ability to perform mild physical
activity

- Being pregnant

- Patients who do not understand or speak Catalan or Spanish.


Collection: Clinical trial registers Database: ICTRP Topics: Long Covid Year: 2022 Document Type: Clinical Trial Register

Similar

MEDLINE

...
LILACS

LIS

Collection: Clinical trial registers Database: ICTRP Topics: Long Covid Year: 2022 Document Type: Clinical Trial Register